Quarterly report pursuant to Section 13 or 15(d)

Oxford Finance Loan Agreement - Additional Information (Details)

Oxford Finance Loan Agreement - Additional Information (Details) - USD ($)				3 Months Ended		8 Months Ended	9 Months Ended		16 Months Ended
	May 09, 2024	May 08, 2024	Feb. 12, 2020	Sep. 30, 2024	Sep. 30, 2023	Jan. 31, 2025	Sep. 30, 2024	Sep. 30, 2023	May 31, 2026	Sep. 30, 2022	Dec. 23, 2020
Debt Instrument [Line Items]
Term loan				$ 40,000,000			$ 40,000,000
Loan Agreement
Debt Instrument [Line Items]
Term loan, aggregate principal amount	$ 100,000,000	$ 60,000,000
Additional term loan advances, description			A $20.0 million term loan was funded on February 12, 2020 (Term A) and another $20.0 million term loan was funded on December 23, 2020 (Term B). Two additional $20.0 million term loans (Term C and Term D) will become available upon achievement of certain clinical development, regulatory and equity-raising milestones, and another $20.0 million term loan (Term E) remains available solely at the discretion of the Lender.
Term loan, interest rate terms							The floating annual rate for each term loan is equal to the greater of (i) 7.75% and (ii) the sum of (a) the 1-month CME Term SOFR reference rate, (b) 0.10%, and (c) 5.98%. Pursuant to the terms of the Fourth Loan Amendment, the Lender agreed to extend the interest-only period from September 1, 2024 to November 1, 2025, with further extensions to as late as November 1, 2026 upon the achievement of certain milestones and the payment of certain fees, and to provide for the repayment of the aggregate outstanding principal balance of the term loan in monthly installments starting on November 1, 2025 through February 1, 2028 (the “Maturity Date”), subject to the potential further extension of the interest-only period.
Term loan, interest rate				7.75%			7.75%
Term loan, effective interest rate				5.98%			5.98%
Term loan, variable interest rate basis							1-month CME Term SOFR
Term loan, variable interest rate basis spread							0.10%
Term loan, maturity date	Feb. 01, 2028
Extended interest only period upon consummation of merger and private placement	Nov. 01, 2025	Sep. 01, 2024
Maturity date subject to the potential further extension of the interest-only period.	Feb. 01, 2028
Extended maturity date upon achievement of certain milestones	Nov. 01, 2026
Term loan, final payment fee percentage			5.00%
Warrant exercisable period from date of issuance							5 years
Interest expense				$ 1,300,000	$ 1,300,000		$ 4,000,000	$ 3,700,000
Loan Agreement \| Advance Prepaid in First 12 Months
Debt Instrument [Line Items]
Term loan, prepayment fee, equal to percentage of the principal amount being prepaid			2.00%
Loan Agreement \| Advance Prepaid After 12 Months But Prior to 24 Months
Debt Instrument [Line Items]
Term loan, prepayment fee, equal to percentage of the principal amount being prepaid			1.00%
Loan Agreement \| Advance Prepaid After 24 Months But Prior to Maturity Date
Debt Instrument [Line Items]
Term loan, prepayment fee, equal to percentage of the principal amount being prepaid			0.50%
Loan Agreement \| First Loan Tranche
Debt Instrument [Line Items]
Term Loan, facilities fee										$ 300,000
Loan Agreement \| Second Loan Tranche
Debt Instrument [Line Items]
Term Loan, facilities fee										$ 300,000
Loan Agreement \| Fourth Loan Amendment
Debt Instrument [Line Items]
Term Loan, facilities fee			$ 1,050,000
Loan Agreement \| Term A
Debt Instrument [Line Items]
Term loan			20,000,000
Term Loan, facilities fee			$ 100,000
Warrants issued to purchase common stock			2,754
Warrant exercise price of common stock per share			$ 72.60
Loan Agreement \| Term B
Debt Instrument [Line Items]
Term loan											$ 20,000,000
Term Loan, facilities fee											$ 75,000
Warrants issued to purchase common stock											1,738
Warrant exercise price of common stock per share											$ 115.00
Loan Agreement \| Term C
Debt Instrument [Line Items]
Term loan				20,000,000			20,000,000
Term loan, facilities fee			$ 50,000
Loan Agreement \| Term D
Debt Instrument [Line Items]
Term loan				20,000,000			20,000,000
Term loan, facilities fee			50,000
Loan Agreement \| Term E
Debt Instrument [Line Items]
Term loan				$ 20,000,000			$ 20,000,000
Term loan, facilities fee			$ 50,000
Loan Agreement \| Scenario Forecast
Debt Instrument [Line Items]
Percentage of aggregate principal amount of outstanding obligations						75.00%			120.00%